Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - renu+lal
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Molecular Detection and Viral-Load Quantification for HIV-1 Groups M, N and O, and Simian Immunodeficiency Virus-cpz (SIVcpz)
This invention provides materials, methods, and assays for detecting HIV-1 groups M and O and optionally HIV-1 group N and simian immunodeficiency virus-cpz (SIV-cpz). Specific nucleic acid primers for hybridization, amplification, and detection of HIV-1 are also provided for. The nucleic acid amplification assays can detect small concentrations of...
Published: 10/28/2024
|
Inventor(s):
Danuta Pieniazek
,
Renu Lal
Keywords(s):
CDC Docket Import
,
CDC Docket Import CDC Prosecuting
,
DA4AXX
,
DA4XXX
,
DAXXXX
,
Detection
,
DXXXXX
,
Groups
,
HIV-1
,
M
,
Methods
,
Molecular
,
N
,
O
,
OID-NCHHSTP-DHPSE
,
REAGENTS
,
VLXXXX
,
VOXXXX
,
VPXXXX
,
WBXXXX
,
WFXXXX
,
WIXXXX
,
WMXXXX
,
XCXXXX
,
XEXXXX
,
YBXXXX
,
YEXXXX
Category(s):
Collaboration Sought > Licensing
,
Collaboration Sought > Materials Available
,
Application > Diagnostics
,
Application > Occupational Safety and Health
,
TherapeuticArea > Ophthalmology
,
Application > Therapeutics
,
Application > Research Materials
,
TherapeuticArea > Cardiology
,
TherapeuticArea > Oncology
,
Application > Consumer Products
,
TherapeuticArea > Dental
,
TherapeuticArea > Endocrinology
,
TherapeuticArea > Infectious Disease
HIV-1 Multi-Clade, Multivalent Recombinant Vaccine Construct
CDC scientists developed immunogenic multi-clade, multivalent (HIV1MCMV) recombinant constructs for use as HIV-1 vaccines. These polypeptides include immunogenic CTL, T- and/or B-cell determinants that are capable of eliciting broad and effective immune responses against diverse subtypes of HIV-1. It is believed that these HIV-1 constructs provide universal...
Published: 10/28/2024
|
Inventor(s):
Sherry Owen
,
Renu Lal
Keywords(s):
CDC Docket Import
,
CDC Docket Import CDC Prosecuting
,
Constructs
,
DB4AXX
,
DB4XXX
,
DBXXXX
,
DC1XXX
,
DC5AXX
,
DC5XXX
,
DCXXXX
,
HIV-1
,
Immunogenic
,
Methods
,
Multi-clade
,
MULTIVALENT
,
OID-NCHHSTP-DHPSE
,
Their
Category(s):
Collaboration Sought > Licensing
,
TherapeuticArea > Infectious Disease
,
Application > Vaccines
,
Application > Therapeutics